FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to new biologically active derivatives of aminoquinoline and aminopyridine. Invention describes compounds of the general formula (I): 
wherein R1 means hydrogen atom or direct or branched (C1-C4)-alkyl group; R2 means hydrogen atom or direct or branched (C1-C4)-alkyl group; R3 means hydrogen atom or direct or branched (C1-C4)-alkyl group or phenyl group, thienyl group or furyl group optionally substituted with one or more direct or branched (C1-C4)-alkyl group, direct or branched (C1-C4)-alkoxy-group or halogen atom; R4 and R5 form in common 1,3-butadienyl group optionally substituted with methylenedioxy-group or one or more direct or branched (C1-C4)-alkyl group, direct or branched (C1-C4)-alkoxy-group, hydroxy-group or halogen atom; R6 means hydrogen atom or cyano-group; R7 means hydrogen atom or direct or branched (C1-C4)-alkyl group, phenyl group, benzyl group, thienyl group, or furyl group optionally substituted with methylenedioxy-group or one or more direct or branched (C1-C4)-alkyl group, direct or branched (C1-C4)-alkoxy-group, hydroxy-group, trifluoromethyl group, cyano-group or halogen atom; X means -NH-group, -NR8-group or sulfur atom, or oxygen atom, or sulfo-group, or sulfoxy-group wherein R8 means direct or branched (C1-C4)-alkyl group or (C3-C6)-cycloalkyl group; n = 0, 1 or 2, and their salts. Also, invention describes a method for preparing compounds of the formula (I). a pharmaceutical composition based on thereof, using compounds of the formula (I) as antagonists of A3 receptors for preparing a pharmaceutical composition used in treatment of different diseases (variants), compounds of the formula (IA), (II), (III) and (IV) given in the invention description. Invention provides preparing new compounds possessing the useful biological properties.
EFFECT: valuable medicinal properties of compounds and pharmaceutical compositions.
15 cl, 6 tbl, 6 dwg, 172 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ISOTOPE-LABELED PRODUCTION QUINOLINES, ACTING AS LIGANDS OF ADENOSINE RECEPTOR A | 2005 |
|
RU2379290C2 |
| DERIVATIVES OF AMINOQUINOLINE AND THEIR USING AS ADENOSINE A3 LIGANDS | 2004 |
|
RU2317290C2 |
| TRIAZOLO[1,5-a]QUINOLINES AS LIGANDS OF ADENOSINE A3 RECEPTOR | 2008 |
|
RU2489432C2 |
| DERIVATIVES OF CYCLIC AMINES, METHOD FOR INHIBITION | 1998 |
|
RU2216540C2 |
| DERIVATIVES OF BENZOTHIAZOLE AND MEDICINAL AGENT BASED ON THEREOF | 2002 |
|
RU2301232C2 |
| CANCER CHEMOTHERAPY USING AZABICYCLO COMPOUND | 2018 |
|
RU2821034C2 |
| DERIVATIVES OF 1,3,5-TRIAZINE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND THEIR USING | 2003 |
|
RU2312859C2 |
| PYRAZOLE[1,5-a]PYRIMIDINE DERIVATIVE | 2006 |
|
RU2390523C2 |
| DEFECATION-PROMOTING PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2294762C2 |
| METHOD FOR PRODUCING ALKYLATED AROMATIC AMIDE DERIVATIVE | 2013 |
|
RU2640302C2 |
